ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,334Medicare Part D Prescriptions Filled, Including Refills

Rank: 25 out of 1111

$949K Total Retail Price of All Prescriptions

Rank: 48 out of 1111

631 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
22% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 631 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

20% of this provider’s 631 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

4% of this provider’s 16,915 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
LISINOPRIL 1,052 889 1 2
AMLODIPINE BESYLATE 841 756 2 7
METOPROLOL TARTRATE 811 699 3 12
HYDROCODONE-ACETAMINOPHEN 792 604 S3 4 1
PRAVASTATIN SODIUM 666 585 5 17
OMEPRAZOLE 619 492 6 4
HYDROCHLOROTHIAZIDE 571 536 7 11
LEVOTHYROXINE SODIUM 558 480 8 3
CITALOPRAM HBR 440 352 9 14
METFORMIN HCL 435 348 10 8
FUROSEMIDE 434 377 11 6
GABAPENTIN 385 301 12 10
ZOLPIDEM TARTRATE 362 276 13 16
TRAMADOL HCL 351 299 14 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 330 279 15 23
LOSARTAN POTASSIUM 328 313 16 34
SIMVASTATIN 295 268 17 5
DOXAZOSIN MESYLATE 284 273 18 87
ATORVASTATIN CALCIUM 254 241 19 15
METOPROLOL SUCCINATE 249 235 20 20
ATENOLOL 237 180 21 22
POTASSIUM CHLORIDE 233 191 22 9
TAMSULOSIN HCL 206 186 23 28
DIOVAN 200 193 24 51
AMITRIPTYLINE HCL 189 102 R 25 64
AMLODIPINE BESYLATE-BENAZEPRIL 158 155 26 67
MIRTAZAPINE 155 119 27 52
CARVEDILOL 147 127 28 21
CLONIDINE HCL 142 99 29 42
CYMBALTA 142 81 29 40
PROAIR HFA 141 109 31 38
CYCLOBENZAPRINE HCL 139 101 R 32 37
ESCITALOPRAM OXALATE 133 117 33 78
ADVAIR DISKUS 133 114 33 43
PLAVIX 132 129 35 49
GLIPIZIDE 130 117 36 57
CLOPIDOGREL 125 114 37 30
PREMARIN 122 110 R 38 90
WARFARIN SODIUM 120 93 39 19
NEXIUM 116 87 40 26
SERTRALINE HCL 114 59 41 24
SYNTHROID 113 85 42 63
SPIRIVA 110 110 43 53
CRESTOR 108 79 44 33
FLUTICASONE PROPIONATE 106 80 45 27
LANTUS SOLOSTAR 104 80 46 135
DIGOXIN 102 88 47 47
ALLOPURINOL 101 90 48 36
PAROXETINE HCL 96 72 49 55
PROMETHAZINE HCL 91 70 R 50 69
MELOXICAM 89 70 51 18
PREDNISONE 89 75 51 48
ALENDRONATE SODIUM 88 88 53 35
LOVASTATIN 83 83 54 41
ROPINIROLE HCL 80 66 55 68
BUPROPION XL 77 54 56 210
ESTRADIOL 76 52 R 57 102
LABETALOL HCL 74 74 58 234
RANITIDINE HCL 71 68 59 29
FLUOXETINE HCL 67 54 60 44
GLIMEPIRIDE 67 42 60 61
PANTOPRAZOLE SODIUM 67 63 60 50
OXYBUTYNIN CHLORIDE 66 52 63 110
METFORMIN HCL ER 65 65 64 84
BUPROPION HCL SR 62 39 65 150
FENTANYL 59 18 S2 66 65
TRAZODONE HCL 57 49 67 32
EXFORGE 56 54 68 224
TRIAMTERENE-HCTZ 55 49 69 80
LEXAPRO 55 49 69 208
DONEPEZIL HCL 53 53 71 25
NAMENDA 52 51 72 31
LOSARTAN-HYDROCHLOROTHIAZIDE 51 24 73 72
FAMOTIDINE 51 31 73 77
PEN NEEDLE 51 33 73 207
LEVEMIR FLEXPEN 50 44 76 178
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 29, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.